Journal Article

FZJ-2016-07679

http://join2-wiki.gsi.de/foswiki/pub/Main/Artwork/join2_logo100x88.png Response Assessment in Neuro-Oncology (RANO) Working Group and European Association for Neuro-Oncology (EANO): Recommendations for the Clinical Use of PET Imaging in Gliomas

Albert, N. L. (Corresponding author) ; Weller, M. ; Suchorska, B. ; Galldiks, N.FZJ* ; Soffietti, R. ; Kim, M. M. ; La Fugére, C. ; Pope, W. ; Law, I. ; Arbizu, J. ; Chamberlain, M. ; Vogelbaum, M. A. ; Ellingson, B. M. ; Tonn, J. C. (Corresponding author)

2016
Oxford Univ. Press Oxford

This record in other databases:      

Please use a persistent id in citations: doi:10.1093/neuonc/now058

Abstract: This guideline provides recommendations for the use of PET imaging in gliomas. The review examines established clinical benefit in glioma patients of PET using glucose (18F-FDG) and amino acid tracers (11C-MET, 18F-FET, and 18F-FDOPA). An increasing number of studies have been published on PET imaging in the setting of diagnosis, biopsy, and resection as well radiotherapy planning, treatment monitoring, and response assessment. Recommendations are based on evidence generated from studies which validated PET findings by histology or clinical course. This guideline emphasizes the clinical value of PET imaging with superiority of amino acid PET over glucose PET and provides a framework for the use of PET to assist in the management of patients with gliomas.

---

Contributing Institute(s):

1. Kognitive Neurowissenschaften (INM-3)

Research Program(s):

1. 572 - (Dys-)function and Plasticity (POF3-572) (POF3-572)

Appears in the scientific report 2016

---

Database coverage:
; Allianz-Lizenz / DFG ; Current Contents - Clinical Medicine ; IF >= 5 ; JCR ; NCBI Molecular Biology Database ; Nationallizenz ; SCOPUS ; Science Citation Index Expanded ; Thomson Reuters Master Journal List ; Web of Science Core Collection

---